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Somatic cells have limited replication capacity, and after a finite number of cell divisions, DNA 
damage is triggered by telomere shortening; thus, the cells enter a state called replicative 
senescence, where DNA is unable to replicate and cell replication is irreversibly stopped. In 
addition, the cells that undergo replicative senescence show great differences in morphology and 
gene expression, even though they maintain their metabolic activity. Although there are many 
studies on the genes associated with differentiation and senescence, there is little information on 
the analysis of related genes and their gene network involved in the terminal differentiation and 
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replicative senescence. Therefore, this study aimed to examine comprehensively the changes in 
the expression of the genes involved in the final differentiation and senescence process and their 
gene networks and functions. Isolated normal human oral keratinocytes (NHOKs) were 
subcultured continuously to obtain the terminally differentiated and replicative senescent cells; 
the state of terminal differentiation or replicative senescence of the cells was verified at the protein 
and RNA level. The total RNAs were isolated from rapidly growing NHOKs and replicative 
senescent NHOKs were analyzed by microarrays using Affymetrix Human Genome U133 Plus 
2.0 Array, the results were confirmed by real-time RT-PCR, and the gene set with altered 
expression were run though the bioinformatical analysis software Ingenuity Pathway Analysis 
(IPA). Microarray results showed increased expression in 1,247 genes and reduced expression in 
1,219 genes. The greatest number of these altered genes was identified as being related to 
biological pathways of transport, cell proliferation, cell cycle, defense and immune response, cell 
death, transcription, apoptosis, and inflammatory response. Several highly-upregulated genes of 
inflammatory response (IL-1β, S100A8, S100A9, MMP1, MMP9, IL-8, BHLHB2, HES1, and 
TWIST1) were observed following the serial subculture in NHOKs. As the terminal 
differentiation and replicative senescence of NHOKs occurred, the expression of inflammation-
related genes such as IL-1β and IL-8 increased. Next, in order to investigate these inflammatory 
genes involved in NHOKs terminal differentiation and replicative senescence, IL-1β was treated 
to rapidly proliferating NHOK cells for 12 to 96 hours, and terminal differentiated and replicative 
senescent cells were treated with IL-1β neutralizing antibody for 14 days. There was an increased 
IL-1β, S100A8, S100A9, MMP1, MMP9 and IL-8 expression of rapidly dividing NHOKs when 
treated with IL-1β, and there was a decreased gene expression of senescing NHOKs when treated 
with IL-1β neutralizing antibodies. Furthermore, in order to confirm this in vivo, the expressions 
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of the genes related to the differentiation or senescence were confirmed by immunocytochemistry 
in gingival tissues of 3-month old and 2-year old mice. Involucrin, p16INK4A, DEC1 (Bhlhb2) and 
IL-1β were strongly expressed in gingival tissues of 2-year-old mice compared to that of 3-month-
old mice. Overall the experiments described in this thesis presents a comprehensive analysis of 
the gene expression pattern of the terminal differentiation and replicative senescence process of 
NHOKs; these results show altered expression of genes associated with biological function of 
protein transport, cell proliferation, cell cycle, defense and immune response, cell death, 
transcription, apoptosis, and inflammatory response. The purpose of this study was to lay the 
groundwork for the understanding of the terminal differentiation and senescence process of 
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The keratinocyte is the principal cell type in the epidermis, primary function of 
keratinocytes is to provide the structural and physical integrity of the skin, thereby 
protecting the body against external injury. Epidermal keratinocytes residing in the basal 
layer of the epidermis differentiate through multiple layers and finally shed as cornified 
dead cells from the skin surface (1,2). The epidermis is composed of four layers, the stratum 
basal layer, spinous layer, granular layer and the stratum corneum. The basal layer in 
normal adult epidermis is restricted proliferative capacity. The products of this proliferative 
process eventually become the post-mitotic cells of the basal layer that are committed to 
the differentiation program. Thus, the epidermis is maintained in a state of self-renewal, 
with continuous proliferation in the basal layer replacing the keratinocytes that are shed 
from the outermost cornified layer (3). The next layer is the spinous layer which consists 
of multiple layers of keratinocytes becoming progressively more flattened with increasing 
distance from the basal layer. In the spinous layer, the synthesis of new keratins begins and 
these proteins are assembled into dense bundles giving the cells a characteristic appearance 
when visualised by transmission electron microscopy (4). As keratinocytes enter the 
granular layer, major differentiation events become evident and markers of differentiation 
are expressed. The first differentiation event is keratinization. The second major 
differentiation-associated event is keratohyalin deposition. The most prominent 
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morphologic feature of keratinocytes of the granular layer is protein-rich granules called 
keratohyalin granules (5). These granules contain profilaggrin, which is a precursor 
molecule to filaggrin. Filaggrin or filament-aggregating protein, facilitates the alignment 
and aggregation of keratin filaments into tightly packed bundles in the cornified cell. 
Filaggrin hydrolysis is a tightly regulated process by which profilaggrin is 
dephosphorylated and proteolytically cleaved first into oligomeric, dimeric, and then 
monomeric subunits and ultimately into amino acids in the outer layers of the stratum 
corneum (6). Free amino acids contribute to the water-holding properties of the stratum 
corneum. The third differentiation event is formation of the cornified envelope, sometimes 
referred to as cell cornification. The proteins involucrin, keratolinin, loricrin, and 
pancornulins are precursor proteins synthesized in the granular layer. They ultimately 
become cross-linked by the enzyme transglutaminase. This results in formation of a rigid 
structural ectoskeleton that serves as a scaffolding for insertion of keratin filaments and a 
barrier to the external milieu. The stratum corneum is the outermost layer of the skin and 
is composed of corneocytes, which are basically anucleate, nonviable keratinocytes that are 
organized into geometric stacks embedded in a lipid-rich intercellular matrix. It is the 
stratum corneum that provides the skin's important barrier functions, such as protecting the 

















Isolation of Keratinocytes 
 
In vitro cell culture is a necessary prerequisite in acquiring a thorough understanding of the 
biology and behavior of the cells of interest and is a critical first step in developing cellular 
therapies. An ability to grow and manipulate primary epithelial keratinocytes in vitro is 
essential to gain insights into the biology of skin that may have clinical implications. The 
dissociation methods of keratinocyte primary culture are well established. There are 
basically two techniques in primary culture: the direct explant and the enzymatic technique. 
Carrel and Burrows described in 1910 a method for the extraction of epithelia cells called 
direct explant (8). The direct explant technique has been used in the culturing of human 
gingival (9). The explant technique has two advantages: The direct explant technique 
obtained the first keratinocytes yield faster than the enzymatic technique, and technical 
handling involved in the direct explant method at the beginning of the process has fewer 
steps (10). 
The enzymatic technique was developed by Daniels et al. (1996), who surveyed the 
success rate of human keratinocyte isolation with various concentrations including trypsin 
and dispase (11). For the isolation of the cells it is necessary to dissociate the dermal and 
epidermal layer without destroying the cells, which is carried out nowadays with enzymes, 
dispase and collagenases, to release the fibroblasts from the dermis (12). Collagenases and 
dispase are formulated for efficient dissociation of tissue from a wide variety of sources. 
Cells were isolated from human foreskin or gingiva tissue to the one-step enzyme 




Differentiation of Keratinocytes 
 
Epidermal differentiation begins with the migration of keratinocytes from the basal layer, 
and ends with the formation of the cornified layer. The rapidly dividing basal keratinocytes 
are devoted to amplifying the epidermal cell population and produce a sufficient number 
of daughter cells that migrate out of the basal layer towards the suprabasal layer at the onset 
of terminal differentiation (13). Cells in the upper layers of the cells lose their ability to 
divide, then exhibit morphological changes that result from the progressive maturation of 
cell structures associated with their upwards migration. In spinous and granular layers, 
keratinocytes continue to prepare the keratinization process. The keratinocytes in the 
stratum corneum are dead squamous cells that are no longer multiplying. When the 
keratinocytes reach the corneum, they are said to be keratinized creating the tough outer 
layer of skin (14).  
Keratinocyte differentiation is associated with changes in gene expression, specifically 
of keratin genes, keratins being the most abundant epidermal proteins. Keratinocytes of the 
basal epidermal layer express keratins K5 and K14. Upon differentiation, when 
keratinocytes exit from the basal layer and migrate upwards into the suprabasal layers, these 
keratins are substituted by K1 and K10 (15,16,17). The K5/K14 pair is expressed in the 
basal layer of the epidermis, which contains epidermal stem cells and transient amplifying 
(TA) cells, while the K1/K10 pair is synthesized only in post-mitotic keratinocytes. Basal 
keratinocytes migrate from the basal into the spinous layers, lose their mitotic activity, and 
begin to synthesize a new set of structural proteins and enzymes that are characteristic of 
cornification. The K1/K10 are among the first proteins to be expressed during cornification 
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(18). In the granular layers, filaggrin and precursors of the cornified envelopes such, as 
loricrin and involucrin, as well as epidermal transglutaminase are expressed (19,20,21,22). 
These are the cornified-envelope proteins, a complex series of lipids are synthesized, some 
of which become covalently attached to proteins of the cornified envelope, and most of 
which form intercellular lamellae that help produce a complete barrier. So, the cornified 
layer is composed of terminally differentiated, dead, cornified, flattened cells that are 
known as corneocytes. These corneocytes mostly consist of keratin intermediate filaments 
embedded in a filaggrin matrix and surrounded by insoluble lipids. Corneocytes are tightly 
attached to each other by modified desmosomal structures, which are proteolytically 
degraded in the uppermost layers of the cornified layer to allow desquamation (23). 
Keratinocyte differentiation in vivo can be modulated by the local environment, for 
example directly by mesenchymal epithelial interactions or indirectly by cytokines 
produced by other cell types. Despite this dependence on environmental influences, it is 
known that the tendency of keratinocytes to stratify and differentiate is retained in vitro, 
even in the absence of instructive information from the connective tissue stroma and/or 
other cells (24). Basal cells of different epithelia which have diverged irreversibly from 
each other during development and use different program of differentiation, maintain this 
information even after serial passaging (25,26). These findings suggest that a culture 
system for human epidermal keratinocytes can be a good model for cellular growth and 













Figure 2. Terminal differentiation in the epidermis. The proteins that are expressed in 







Cellular senescence has been defined as the terminal phase of passaged primary cell 
populations (27). It is in fact a biologically irreversible state of cell growth arrest for which 
some investigators prefer the more precise term of replicative senescence (28). The 
senescence growth arrest is essentially permanent and cannot be reversed by known 
physiological stimuli (27). Cellular senescence refers to an irreversible fate of damaged 
cells that is induced by a variety of stressors, including end of replicative lifespan, 
oncogenic stimuli, DNA damage, and mechanical stress (27,28,29,30). Unlike apoptosis, 
which results in the elimination of damaged cells, senescence leads to viable and 
metabolically active cells which have permanently arrested replication through a complex 
and multi-faceted cellular programming (31,32). A prime cause of replicative senescence 
in human cells is progressive telomere shortening (33,34,35). Telomeres consist of 
repetitive DNA elements at the end of linear chromosomes that protect the DNA ends from 
degradation and recombination (36,37). Due to the intrinsic inability of the replication 
machinery to copy the ends of linear molecules, telomeres become progressively shorter 
with every round of cell division (38). Finally, telomeres reach a short length, behaving as 
double-stranded DNA breaks in telomere initiated senescence or apoptosis (39). Without 
telomeres dysfunction, DNA damage involve the induction of replicative senescence by 
telomere attrition has been established (40,41). DNA damage accumulates with age and 
that this may be due to an increase in production of reactive oxygen species (ROS) and a 





Senescent cells have several different characteristic functional and morphologic 
phenotypes. (a) Most senescent cells also express the tumor suppressor protein p16INK4A 
(44,45,46). This protein activates the retinoblastoma (RB) gene whose primary function is 
to repress transcription genes needed for cell cycle (47). Tumor suppressor protein p16INK4A 
is believed to be a late marker of a sustained DNA damage response and its expression is 
found to be increased with age. (b) Senescent cells also express a senescence-associated β-
galactosidase (SA-β-gal), which is reflected by the increase in lysosomal mass, but, there 
is no clear evidence pointing to an actual involvement of this enzyme in the senescence 
response (27). Commercially available products are available that allow identification of 
SA-β-gal in cytoplasm of senescent cells, resulting in blue staining cells. SA-β-gal is the 
most widely used marker of senescence; however there is no universal or specific marker 
for cellular senescence (48). (c) Senescent cells obtain distinct phenotypic traits, including 
chromatin modifications and profound changes in protein secretion, which are referred to 
as the senescence-associated secretory phenotype (SASP) (49). Senescent cells increase in 






Microarray allow many genes to be studied in the same experiment rather than one gene at 





relationships between individual genes. Microarray has been used to elucidate wide gene 
expression profiling, protein binding site and single nucleotide polymorphism (SNP) (51).  
Changes in gene expression are associated with numerous biological processes, cellular 
responses and disease states. The availability of microarrays has made it possible to study 
gene expression in a high-throughput fashion and gather insights about biology and disease. 
In recent years, a massive amount of microarray studies has been conducted and numerous 
datasets generated. Microarray platforms enable the comparison of thousands of genes 
expressed in a cell at any given time which are simultaneously monitored; they have been 
applied to study the effects of development and ageing on gene expression (52). 
The gene expression profile can be observed with spotted microarray of short segments 
of DNA oligonucleotides representing whole genome of an organism which is then 
hybridized with fluorescent labeled cDNA probes synthesized in bulk from mRNA. The 
fluorescent intensity of a spot reflects the relative expression level of each corresponding 
gene. The labeled cDNA probes have been prepared by direct incorporation of Cy3 or Cy5 
labeled dNTP. Alternatively, chemically modified dNTP can be used to improve 
fluorescence intensity (https://www.affymetrix.com). 
Microarray analysis attempt to extract biological meaning from massive amounts of 
gene expression data. Clustering has been one of the most successful methods for extracting 
coordinately regulated sets of genes. A system of cluster analysis for genome-wide 
expression data from microarray hybridization is described that uses standard statistical 
algorithms to arrange genes according to similarity in pattern of gene expression. The 
output is displayed graphically, conveying the clustering and the underlying expression 





assigned to the gene ontology terms or pathway resources using annotations from public 
databases (53). Gene Ontology (GO) provides a powerful source of information to be used 
to cluster annotation based on biological background. The GO is a resource, in the form of 
a structured ontology, which describes and categorizes gene product functions in distinct 
categories and the relationships between them. The GO functional categories are classified 
in three general categories: biological process, molecular function, and cellular component. 
The biological process category contains individual GO terms that describe processes 
associated with molecular events and pathways representing multiprotein-dependent 
functions. The molecular function category, in contrast, describes basic gene functions at 
the molecular level. Lastly, the cellular component category describes the location, 







Normal human somatic cells undergo a limited number of cell proliferation, eventually 
reaching an irreversible cell cycle arrest known as replicative cellular senescence (12,56). 
Senescent cells remain viable and metabolically active, but are unable to proliferate despite 
the presence of mitogens and nutrients (27). The number of times that a cell divides before 
entry into senescence is highly variable, depending on the cell type and the organism from 
which it was originally derived.  
In a previous study, the senescence is a complex process that regarding to the cellular 
senescence and decreased proliferative ability, reduction of cellular DNA repair capacity, 
loss of telomeres with advancing age (30,56), point mutations of extranuclear 
mitochondrial DNA (mtDNA) (28), increased oxidative stress and increased frequency of 
chromosomal abnormalities (12,57,58,59). Human aging is developed from such an 
accumulation of the molecular mechanisms. Despite these advances our knowledge on 
human ageing still remains limited. 
Among the normal human somatic cells, epidermal and mucosal keratinocytes migrate 
from the basal layer to the surface (60), where they terminally differentiate, arrest cell cycle 
at G1, and ultimately lose their nuclei to become corneocytes in vivo (59). Terminal 
differentiation of keratinocytes shows proliferation arrest, which is known as replicative 
senescence. Replicative senescence results from prolonged proliferation in culture of 
primary cells after serial passaging in vitro (29). Primary NHOKs underwent 
approximately 19~25 population doublings (PD) when serially subcultured (61). 





also been associated with cellular senescence in oral keratinocytes (44,61). Although 
previous studies have demonstrated that adult oral keratinocytes undergo differentiation 
and senescence (44,62), however, the knowledge about the regulatory network that receives 
senescence signals and initiates the senescence response is still lacking.  
To better understand the network of genes involved in the senescence process in NHOK, 
we performed microarray based gene expression profiling in exponentially replicating cells 
compared with senescent cells. Microarrays are used to measure the transcript abundance, 
or levels of gene expression of mRNA transcribed from each gene in the genome (53). A 
vast amount of gene lists can be uploaded into the server and used to identify molecular 
networks, key biological functions and common cellular pathways by using a 
bioinformatics software such as IPA. This technology has provided an opportunity into the 
genome-wide expression patterns, like cellular signaling, cellular growth, cellular 
development and functions of terminal differentiation and replicative senescent cells (63). 
Identifying differentiation and senescence regulated functional gene groups based on 
regulatory and gene expression information. Above all, in vitro and in vivo studies 
exhibited a close relationship between differentiation and senescence of NHOKs. A major 
goal in keratinocyte biology is to identify genes, pathways, and networks that control 






MATERIALS AND METHODS 
 
Culture of Primary Cell  
 
Primary normal human oral keratinocytes (NHOKs) were prepared from keratinized oral 
epithelial tissues according to methods previously reported (64). Briefly, Healthy human 
gingival tissue specimens obtained from patients (age range 20 to 50 years) who were 
undergoing oral surgery. The gingival tissue samples were washed three times with Hanks’ 
balanced salt solution (HBSS; GIBCO) supplemented with 0.03% sodium bicarbonate 
(GIBCO). To separate epithelial layer from underlying fibrous connective tissue, the tissues 
were incubated in HBSS containing collagenase (type II, 1.0 mg/ml; Sigma-Aldrich) and 
dispase (grade II, 2.4 mg/ml; Boehringer-Mannheim) for 90 minute at 37°C in humidified 
95% air and 5% CO2. Primary oral keratinocytes were prepared from separated epithelial 
tissue by trypsinization and maintained in complete keratinocyte growth medium (KGM; 
Lonza) supplemented with bovine pituitary extract, recombinant human EGF, insulin, 
hydrocortisone, gentamicin. Approximately 70% confluent primary NHOK were plated at 
1x105 cells per 60-mm culture dish, cultured for 7-10 days. The confluent primary cells 









Generation of Cell Differentiation and Replicative Senescence 
 
NHOKs were serially subculture was performed when the cells reached 70% confluence. 
NHOKs were plated at 1x106 cells per 100-mm culture dish and cultured until the cells 
reached 70% confluence. Every 70% confluence until they reached the post-mitotic stage 




Cell Culture and Treatment 
 
NHOKs were cultured under standard conditions (humidified atmosphere, 5% CO2 at 37°C) 
in keratinocyte growth medium (KGM; Lonza) supplemented with bovine pituitary extract, 
recombinant human EGF, insulin, hydrocortisone, gentamicin; media were replaced every 
48 hours. To determine the cellular senescence by IL-1β induction, proliferating NHOKs 
were incubated with 10 ng/ml of recombinant human IL-1β for 12, 24, 48, 72, and 96 hours, 
or 0.1% BSA. To identify the protection of cellular transformation by IL-1β, senescing 
NHOKs were treated for 14 days with 10 ng/ml of human IL-1β/IL-1F2 neutralizing 
antibody. The exponentially growing NHOKs reached 70% confluent, required sub-







Determination of Population Doublings 
 
Isolated NHOKs were plated in 60-mm culture dishes. Three days after seeding, the number 
of cells that had been originally plated was determined by colony counting. Cells were 
cultured until they reached 70% confluence and then the cell numbers in the dishes were 
counted in a hemocytometer. This count allowed determination of the number of PD of the 
primary cultures. And the cumulative PD were determined based on the number of NHOK 
harvested at every passage. The PD was calculated at the end of each passage by the 
formula, 2N = (Cf/Ci), where N denotes the number of PDs; Cf, the total number of cells 





Senescent NHOKs were identified by their ability to stain positively for β-galactosidase, 
as previously described (27). Briefly, cells were fixed with 3% formaldehyde/ 0.2% 
glutaraldehyde for 10-15 minute at room temperature. The cells were then stained for SA-
β-gal activity in freshly prepared staining solution. Staining was evident for 12-16 hours at 
37°C (no CO2). The presence of β-galactosidase activity was evidenced by a blue color in 







Western Blot Analysis 
 
Western blot analysis was performed as in previous report (64). Briefly, whole cell extracts 
from the cultured cells were isolated using lysis buffer (50 mM Tris-HCl [pH = 7.4], 150 
mM NaCl, 1 mM EDTA [pH = 8.5], 1% Triton X-100, 1% sodium deoxycholate, 0.1% 
SDS, 1 mM β-glycerophosphate disodium salt hydrate, 2 mM sodium orthovanadate, and 
1 mM phenylmethanesulfonyl fluoride [PMSF]; Sigma-Aldrich) and then separated by 
SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to Immobilon protein 
membranes (Millipore). The membranes were incubated with the primary antibodies and 
probed with the respective secondary antibodies conjugated with HRP. Antibodies for 
involucrin (SY5; Sigma-Aldrich), transglutaminase (Ab-1; Oncogene), p16INK4A (C-20; 
Santa Cruz), and β-actin (20-33; Sigma-Aldrich). Antigen-antibody complexes were 
visualized using ECL Western blotting detection system (Intron biotechnology).  
 
 
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
 
Purification of total RNA was prepared from the cultured NHOKs at 8 different time points 
(PD 10.0, 12.1, 14.1, 17.0, 19.4, 21.3 and 21.6) of keratinocyte differentiation and 
senescence using the RNeasy Mini kit (Qiagen). Total RNA was reverse transcribed to 
cDNA, which was used for PCR amplification of involucrin (31 cycles), transglutaminase 





second, annealing at 60°C for 10 second, and extension at 70°C for 10 second). The RT-
PCR primers used for analysis of involucrin, transglutaminase, p16INK4A, and GAPDH 
genes were represented in Table 2. The PCR products were electrophoresed on a 1.5% 





Total RNA was isolated from the cultured cells using TRI-reagent (Molecular Research 
Center) and purified through RNeasy Mini kit (Qiagen). The cDNA was prepared using 
SuperScript™ III Reverse Transcriptase (Invitrogen) and a random hexamer and then 
subjected to real-time PCR amplification using SYBR® Green PCR Master Mix (TaKaRa). 
The quantitative real-time RT-PCR analyses were performed using a 7500 Real-time PCR 
System (Applied Biosystems). The thermal cycling for all reactions was follows: 95°C for 
4 minute, followed by 40 cycles of 95°C for 15 second, 60°C for 20 second and 72°C for 
34 second. Real-time RT-PCR primers used for analysis of involucrin, transglutaminase, 
p16INK4A, and GAPDH genes were represented in Table 2. Each assay was normalized to 
GAPDH or HPRT1 mRNA levels. In addition, the real-time RT-PCR primers used for 
analysis of network genes were represented in Tables 3-7. The real-time RT-PCR primers 










Cells plated at a density of 4x106 cells/100-mm culture dishes were cultured and detached 
by gentle treatment 0.125% trypsin-EDTA (GIBCO) in DPBS. Cells were collected, 
washed once with cold DPBS and fixed in 70% ice-cold ethanol at 4°C for 30 minute. Cells 
were washed twice with DPBS and incubated for 30 minute at 37°C in 0.5 ml DPBS 
containing 100 μg/ml RNase A, 50 μg/ml propidium iodide (Sigma-Aldrich), and 0.05% 
Triton X-100. The cell cycle phases (Sub-G1/G0, G1, S, G2/M) of each group were 
calculated using the cell DNA content reflected by PI fluorescence intensity. The data were 





Gene expression profiling was performed between exponentially growing keratinocytes 
(PD 14.1) and terminally differentiated and senescent keratinocytes (PD 21.6), using the 
GeneChip™ Human Genome U133 Plus 2.0 Array from Affymetrix. Total cellular RNA 
was isolated from the cultured NHOKs (PD 14.1 and PD 21.6) using TRI-reagent 
(Molecular Research Center) and further purified through the RNeasy Mini kit (Qiagen). 
cDNA was synthesized using a GeneAmp RNA PCR kit (Applied Biosystems) from the 
extracted total RNA samples. Labeled cRNA was synthesized using a Quick Amp labeling 





labeled cRNA from RNA samples of proliferating keratinocytes (PD 14.1) or terminally 
differentiated and senescent cells (PD 21.6) was hybridized to a GeneChip™ Human 
Genome U133 Plus 2.0 Array (Affymetrix) according to the manufacturer’s protocol. The 
expression profiling of more than 47,000 annotated genes was compared rapidly 
proliferating cells (PD 14.1) and replicative senescent cells (PD 21.6). Arrays were scanned 
using Agilent microarray scanner (Agilent Technologies), and the scanned images were 
captured using Agilent feature extraction software. The data was imported into GeneSpring 
GX software (Agilent Technologies) for the selection of up-regulated and down-regulated 
genes. By applying more stringent criteria and including only genes that showed a 
significant (P < 0.05) expression difference of at least 2-fold between PD 14.1 and PD 21.6 
cells. Expression levels in the samples were normalized to the media of the corresponding 
sample. Genes with an expression up- or down-regulated by at least two-fold were used for 
further analysis with IPA. The results obtained from the microarray analysis were 
confirmed by real-time reverse transcription-polymerase reaction (RT-PCR) of selected 
genes in the senescence associated genes. 
 
 
Ingenuity Pathways Analysis 
 
Comparative analysis of gene microarray data was performed using an IPA software 
version 4.0 (Ingenuity Systems) (51). IPA identified significant gene networks, top 











In situ expression of involucrin, p16INK4A, IL-1β, DEC1 and VEGF were determined in 
tissue specimens by immunohistochemistry. Mouse gingival tissues were obtained 3-
month-old mice and 2-year-old mice. Mouse gingival tissues dissected and fixed 
immediately by formalin. Tissue specimens were processed for paraffin wax embedding 
and 4µm sections were prepared from each block for examination. Involucrin (1:200; 
Abcam), CDKN2A/p16INK4a (1:200; Abcam), IL-1β (1:200; Santa Cruz), DEC1 (1:100; 
gift from Y Kato, Hiroshima University Graduate School of Biomedical Sciences, 
Hiroshima, Japan), and VEGF (1:100: Santa Cruz) antibodies were used as primary 
antibodies. CSA system (DAKO) was employed. Sections were initially immersed in 
Target Retrieval Solution (DAKO) at 97°C for 20 minute, and subsequent steps were 
performed according to the manufacturer’s instructions. The immunostaining of all mice 
gingival tissue specimens was performed simultaneously to ensure the same antibody 











For real-time RT-PCR experiments were performed at least triplicate. The data were 
expressed as the mean ± standard deviation (SD). Comparisons between multiple groups 
was analyzed using a one-way analysis of variance (ANOVA) followed by Student’s t-test. 








Serial Subcultures of Primary NHOKs  
 
Primary NHOKs cultures from three different donors were prepared from separated 
epithelial tissue. Three days after seeding, colonies of rapidly dividing NHOK and serially 
subcultures until they have irreversibly lost the ability to proliferate. NHOKs reached the 
senescent phase of proliferation, at that time the culture was maintained for 12-14 days 
without further passage. NHOKs were serially subcultures until the cells stopped division, 
and the numbers of cumulative population doublings were determined at each passage. 
Normal human cells PD only a finite number of times, depending on cell type, donor age 
and genotype, and history of the tissue. Changes in the morphological features of NHOKs 
during in vitro culture were examined by phase contrast microscopy at different PD of 
replication. Lower PD (<PD 14.1) of primary NHOKs displayed the typical keratinocyte 
morphology and retained an undifferentiated phenotype. NHOKs showed signs of 
differentiation when they reached PD 19.4 (Fig. 3a) but, the majority of the cells at this 
doubling level still maintained the replicating epithelial cell morphology. At PD 21.6, non-
dividing cells displayed the characteristics of terminal differentiation, including a flat, 
highly enlarged and elongated cytoplasm, and terminally differentiated cells started to 
round up and detach from the culture dish (Fig. 3a). On the basis of the shape of the 
proliferation curve (Fig. 3b), NHOKs proliferated well until passage number 4, constituting 





of cell proliferation and apparently proliferated at a markedly reduced rate. After passage 
number 7 or 8, there were not enough cells to establish the subsequent passage, and the 
serial subculture was stopped at this point. To understand the distinction between 
replication, differentiation, and senescence of NHOK in vitro, we determined the 
morphological features, molecular markers of keratinocyte differentiation and senescence, 
and staining of cells for SA-β-gal activity.  
 
 
Serial Subcultures Induce Cell Differentiation of NHOKs 
 
Differential expression of involucrin and transglutaminase which is the molecular markers 
for keratinocyte differentiation (12,58,61). To detect keratinocyte differentiation, Western 
blot, real-time RT-PCR, and RT-PCR, were employed to examine the NHOKs cultures at 
different time points (Fig. 4a-c). During the proliferative phase, faint or weak expression 
was observed for involucrin and transglutaminase proteins (Fig. 4a). The expression of 
involucrin and transglutaminase gradually increased to a maximum after the beginning of 
the senescent phase after the majority of the cells had stopped dividing (Fig. 4a-c). These 









Serial Subcultures Induce Replicative Senescence of NHOKs  
 
Cell senescence was assessed by p16INK4A expression and β-galactosidase staining analysis. 
p16INK4A protein is reported in studies on the replicative senescence of normal human 
epidermal keratinocytes (65), and is believed to be an essential element in senescence. 
p16INK4A levels are low or undetectable in exponentially growing phase, but significantly 
increased in the serially subcultured keratinocytes with increasing PD numbers (Fig. 5a-c). 
In particular, the level was extremely high in cultures at the senescent stage (PD 21.6).  
Morphological features of NHOKs during serial cultures were examined by phase 
contrast microscopy at different PDs (PD 12.1 and PD 18.1). Exponentially growing cells 
(PD 12.1) were undifferentiated phenotype, small and polygonal in shape with large nuclei 
containing prominent nucleoli (Fig. 5d, left). Non-dividing cells at PD 18.1, most cells 
displayed the characteristics of replicative senescence, such as larger overall, and contained 
clear round and vacuolated spaces in the perinuclear cytoplasm (Fig. 5d, right). Cells in the 
senescing phase (PD 18.1) were larger with a proportionately larger cytoplasmic 
compartment. The most notable change in cells entering senescence was a dramatic 
increase in the number and size of clear vacuoles that occupied most of the perinuclear 
cytoplasm.  
Senescence associated-β-galactosidase activity is a useful marker for senescent cells. 
Increased SA-β-gal activity, G1 cell cycle arrest and decreased telomerase activity are 
classic characteristics of senescent cells (27). In order to determine if the replicative 
senescence results from the serial subcultures of NHOKs, the SA-β-gal activity was 





replicative senescence, showing SA-β-gal positive staining (Fig. 5e, right). The combined 
results from use of both p16INK4A and SA-β-gal indicate that serial subculture of primary 
NHOKs induces replicative senescence. 
 
 
Cell Cycle Distribution Analysis of Proliferating NHOKs 
 
The proliferative activity of the cell cultures was analysed with flow cytometric techniques. 
The flow cytometric measurement of propidium iodide (PI) stained DNA is shown in Fig. 
6. To verify whether the PD 14.1 cells grow as exponentially growing cells, we measured 
cell cycle distributions of PD 10.0, 12.1, and 14.1 cells by fluorescence-activated cell 
sorting (FACS) analysis. The appearance of the sub-G1 phase is indicative of the 
occurrence of apoptosis. Percentage of cells in sub-G1/G0 fraction (0.17%, 0.33%, and 
0.58%) was extremely low in cells at PD 10.0, 12.1, and 14.1 (Fig. 6), suggesting that PD 
14.1 cells are considered as exponentially growing cells. Cell cycle phases were similar to 
different PD (Fig. 6). 
 
 
Gene Expression Profiling of NHOKs via DNA Microarray  
 
The differential gene expression profiling was performed between rapidly proliferating 





Using the Affymetrix Human Genome U133 Plus 2.0 Array, the expression level of more 
than 47,000 transcripts and including approximately 38,500 characterized human genes. 
The data was imported into GeneSpring GX software for the identification of different state 
of activation or repression in the cells. These identified genes were categorized into distinct 
gene groups based on their known functions as shown in Table 10. Statistically significant 
(p < 0.05) differences were further reduced using the selection criteria cutoff (> 2-fold 
difference). As a result, 1,247 genes were upregulated, and 1,219 genes were 
downregulated compare to terminally differentiated and senescent (PD 21.6) NHOKs 
versus exponentially replicating (PD 14.1) NHOKs. Transcripts of genes involved in 
cellular movement, cellular differentiation, cell cycle regulation, chemokines and 
inflammatory factors were up-regulated in PD 21.6 cells. The expression of a subset of 
genes implicated in cellular proliferation was decreased in PD 21.6 cells, together with a 





To further refine the significance of the altered genes identified in senescent stage of up-
regulated gene expression data, we performed network analysis using the IPA. These 
networks indicated functional relationships among gene products based on known 
interactions reported in the publications. A network was defined as known biological 
pathways between the uploaded predicted targets (called focus genes) and other interacting 





(Table 1) were identified by functional network analysis using the IPA. In particular, these 
networks were associated with cellular movement, development and function, cellular 
growth and proliferation and apoptosis. Table 1 shows these cellular functions. The focus 
molecules that were associated with these networks were IL-1β, S100A8, S100A9, MMP1, 
MMP9, and IL-8 (Fig. 7). The expression levels of the genes within these networks were 
confirmed by quantitative real-time RT-PCR and found similar results compared with 




Confirmation of High Levels of Marker Genes Associated with 
Senescence in Terminally Differentiated NHOKs via Real Time RT-
PCR 
 
Among the genetic networks identified, we focused on the cellular differentiation and 
senescence. Focus genes identified by the IPA program were associated with cellular 
movement and potential targets of the differentiation. We chose to evaluate the expression 
of IL-1β, S100A8, S100A9, MMP1, MMP9, and IL-8; these genes were potential target 
genes for terminal differentiation or replicative senescence of human oral keratinocytes. To 
confirmed that IL-1β, S100A8, S100A9, MMP1, MMP9, and IL-8, real-time RT-PCR was 
performed. These genes mRNA expression was significantly increased in replicative 





between the groups (Table 1, Fig. 8a-e). In order to validate the results obtained from IPA, 
we measured the expression of some selected genes. As shown in Fig. 8a-e for each of the 
examined genes, the real-time RT-PCR results similar the expression levels for these genes 
assessed by microarray analysis.  
 
 
Induction of Cellular Senescence by IL-1β in Exponentially Growing 
NHOKs 
 
To determine the molecules involved in the regulation of cellular senescence by IL-1β 
induction, exponentially growing NHOKs (PD 14.1) were treated with human recombinant 
IL-1β (10 ng/ml) for 12-96 hours. Steady-state levels of IL-1β, S100A8, S100A9, MMP1, 
MMP9, and IL-8 mRNAs derived from exponentially growing oral keratinocytes were 
consistently up-regulated in the presence of IL-1β, as determined by real-time RT-PCR 
analysis (Fig. 9a). VEGF mRNA expression was up-regulated after 72 hour of incubation 










Protection of Cellular Transformation by IL-1β Neutralizing 
Antibody in Senescing NHOKs 
  
To identify the function of IL-1β in the protection of cellular transformation, human IL-
1β/IL-1F2 neutralizing antibody (10 ng/ml) was treated for 14 days to determine the 
expression of inflammatory molecules in the senescent and terminally differentiating cells. 
The concentration used in the experiment was not toxic for the cells as judged by MTS 
assay (data not shown). IL-1β neutralizing antibody suppressed the senescence phenotypes 
caused by senescence and terminal differentiation (Fig. 9b). 
 
 
Expression of Genes Associated with Ageing at Gingiva of Young and 
Aged Mice via Immunohistochemistry 
  
Because terminally differentiated and senescent keratinocytes showed an increase of 
involucrin and p16INK4A, we investigated whether these findings are relevant to the 
epithelium of young mice and old mice gingival tissues in vivo (Fig. 10a and 10b). We 
analyzed involucrin, p16INK4A, IL-1β, DEC1 and VEGF expression in gingival tissue 
sections from the 2-years and 3-months old mice. Immunohistochemical staining showed 
robust levels of involucrin and p16INK4A in the 2-years old mice gingival tissues compared 
with that in tissues derived from 3-months old mice (Fig. 10a). Furthermore, IL-1β and 





epithelial cells, but the number of IL-1β and DEC1 positive cells in the basal layer was 
dramatically increased in 2-years old mice gingival tissues. In contrast, VEGF-positive 
cells in the basal layer was reduced in aged mice gingival tissues (Fig. 10b). Involucrin, 
p16INK4A, IL-1β and DEC1 increased in the epithelium of old mice gingival tissues. These 
results revealed that a rise in involucrin, p16INK4A and IL-1β marks senescence of primary 











Primary NHOK undergo a finite number of replications during serial subcultures before 
entering a senescent phase, characterized by the loss of replicating potential and 
morphological alterations, followed by differentiation and senescence (12,27,44,61). In this 
study, evaluated the gene transcriptional profiles during subculture-induced cell 
differentiation and senescence in NHOKs. The serial subculture of primary NHOKs to the 
post-mitotic stage results in differentiation, as evidenced by increased involucrin and 
transglutaminase protein, the molecular marker of keratinocyte differentiation (12,58,61). 
Key characteristics of senescence are the p16INK4A is known to be a cellular factor 
responsible for the onset of senescence in normal cells (65,66). The activation of p16INK4A 
is believed to be a marker of a sustained DNA damage response and its expression is found 
to be increased with age (66,67,68). In this study, the level of cellular p16INK4A protein 
gradually increased with the serial subculture of primary NHOKs. The most commonly 
used marker is senescence associated β-galactosidase (SA-β-gal) activity, which reflects 
the increased lysosomal content of senescent cells (27). These results indicate that serial 
subculture of these primary keratinocytes induces replicative senescence. The microarray-
based analysis, we demonstrated NHOKs transcriptional signatures profiling to specific 
molecular networks with gene expression patterns. The number of microarray datasets of 
1,247 genes were differentially expressed in the oral keratinocytes in response to the serial 
subculture.  
The greatest number of these altered genes was identified as being related to biologic 





apoptosis, and inflammatory cytokines, suggesting that the serial subculture was able to 
induce a multitude of specific gene expression changes during differentiation and 
senescence. To examine the molecular function genetic networks, the data that we 
generated from the microarray was explored using ingenuity pathways analysis. The 
information generated from the Ingenuity knowledge base is consistent with the role of 
these genes in differentiation and senescence. Using the IPA tool, top five molecular 
networks identified in Table 1 as well as the primary molecular and cellular functions 
indicated in Fig. 7. The information generated from the Ingenuity knowledge base is 
consistent with the role of the cytokines in senescence. Therefore, we focused on the targets 
that are regulators of cellular proliferation with the hypothesis that an increased cytokine 
expression in the aging cells would be associated with differentiation and senescence. 
IL-1β and IL-8 regulation of genes related to inflammation in human keratinocytes and 
endothelial cells (69,70,71). In this study, treatment with the human recombinant IL-1β in 
exponentially growing NHOKs led to premature senescence. The effect of inhibiting IL-1β 
was further confirmed using IL-1β neutralizing antibodies. IL-1β neutralizing antibody 
suppressed the senescence phenotypes caused by senescence and terminal differentiation. 
These results suggest that IL-1β plays an important role in the regulation of cellular 
senescence and might contribute to tissue or cellular aging. The highly up-regulated level 
of IL-1β expression during the serial subculture, recombinant human IL-1β-treated primary 
normal human keratinocytes, and gingival epithelium of aged mice clearly demonstrates 
that are induced to overcome this replicative senescence. 
S100A8 is related to the photoaging and intrinsic aging of human skin (72). A recent 





inflammatory proteins S100A8/A9 and their amyloids (73). The current finding of 
upregulation of expression of S100A8/S100A9 in aging cells clearly suggested a novel 
view of the response to this serial subculture, and these genes may function in vivo as a 
major barrier against the replicative senescence. 
Upregulation of MMP1 (matrix metalloproteinase-1) contributes to inflammatory cell 
intimal infiltration, plaque instability and rupture and is correlate with increased total 
plaque burden (74,75,76). Metalloproteinase are also implicated in multiple phases of 
atherosclerosis (77). 
A significant transcriptional change is also observed with VEGF expression in aging cells. 
Cells from old animals express significantly lower levels of VEGF (78). Downregulation 
of VEGF and upregulation of p16 occur in aged cells (79). VEGF secretion of cells from 
aged mice is also decreased (80). Therefore, it is likely that a decreased VEGF expression 
in the aging cells may be linked with senescence.  
DEC1 transcription factor, has been shown to play a role in the cell cycle regulation 
(79), differentiation (81), and apoptosis (79) in response to extracellular stimuli. DEC1 is 
induced by DNA damage in a p53-dependent manner and mediates p53-dependent cell 
cycle arrest and senescence (82). In the present study, an increased DEC1 expression with 
aging is reflective of a reduced proliferation capacity of the cells, suggesting that inhibition 
of ID1 expression is a mechanism by which DEC1 inhibits cell proliferation and promotes 
premature senescence. 
In conclusion, the present study provided a comprehensive gene expression profile of 
primary NHOKs that accompanied subculture-induced cell differentiation and senescence. 





specific gene expression changes, there appeared to be some targeted biological pathways 
that were more selectively altered and could provide some guidance for further 
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Table 1. Functional networks in the exponentially growing (PD 14.1) and terminally 
differentiated and replicative senescent (PD 21.6) NHOKs 
 
Network           Focus genesa                     Scoreb    Top functions  
 
1 ↓ALDH7A1, ↑ANGPTL4, ↓ASS, ↓BAMBI, 36 Cell death, 
 ↓CBS, ↓CEBPG, ↑DCN, ↓DDIT3, ↓FST,   
 ↑GM2A, ↓HMGN2, ↓HPSE, ↑IL-1B, ↑IL1F5,  Renal and 
 ↓IL1RAP, ↑INHBA, ↓JDP2, ↑KLF11,   urological disease, 
 ↑MARCKSL1, ↑MMP3, ↑OAS2, ↓OGG1, ↑PGF,   
 ↑PIM3, ↓PPP1R14A, ↓PROCR, ↑RNASE7,  Cancer 
 ↑S100A8, ↑S100A9, ↑SAA1, ↓SLC11A2,   
 ↑SLC20A1, ↓SLC37A4, ↑SOD2, ↑UGCG   
    
2 ↑ADAMTS1, ↑CLDN1, ↑CTGF, ↑CYR61, 36 Cancer, 
 ↑DDR1, ↑DUSP4, ↓EMP2, ↓ETV4, ↓ETV5,   
 ↓FBLN1, ↓FGF2, ↑FN1, ↓GART, ↓HYOU1,  Cellular movement, 
 ↓FBLN1, ↓FGF2, ↑FN1, ↓GART, ↓HYOU1,   
 ↓IGFBP2, ↑ITGA2, ↑ITGA5, ↑ITGB6, ↑ITGB8,  Cardiovascular system, 
 ↑MFAP5, ↑MMP1, ↑MMP14, ↓NUP88, ↑S100A4,   
 ↑S100A7, ↓SH2D2A, ↑SPINK1, ↓STK16, ↑TFP1,  Development & function 
 ↑TGM2, ↑TIMP2, ↓VEGF, ↓VEGFB, ↓VRK1,   
 ↓ZNF410   
    
3 ↑ADAM9, ↑ADAM19, ↓AREG, ↓CBLC, ↓CDH4, 36 Cellular Growth & 
 ↑CEACAM6, ↓CKS2, ↓COL4A2, ↑COL5A2,  Proliferation, 
 ↑CXCL1, ↑CXCL5, ↑CXCL14, ↑DUSP6,   
 ↓EGFR, ↓EREG, ↓ERRFI1, ↑GRB7, ↓GRB10,  Cancer, 
 ↓GTF3A, ↑HBEGF, ↑IL-8, ↑IL32, ↓MKI67,   
 ↑MMP9, ↓NFIB, ↓NRG1, ↓PACSIN3, ↑PTGS2,  Cellular Movement 
 ↓RNF41, ↑SH3KBP1, ↑SLP1, ↑SOX4,   
 ↑SPRY2, ↓TOM1L1, ↓ZNF259   
    





4 ALPΔ, ↑BHLHB2, ↑BMP2, ↓C18ORF37, ↓DEK, 25 Gene expression, 
 ↓EIF5A, ↓ELOVL6, ↓FOXG1B, ↑HES1, ↑ID3,   
 ↑KPNB1, ↓MCRS1, ↓MGC21874, ↓NFATC3,  Cell signaling, 
 ↓NUP98, ↓NUP153, ↓P8, ↑PCAF, ↓PPAN,   
 ↓RANBP1, ↓RCC1 (includes EG: 1104),  Cellular development 
 ↓RUVBL1, ↓SITPEC, ↓SMAD1, ↓SNRPA,   
 ↑SOX9, ↓SRRM1, ↓TACC3, ↑TGM1, ↑TLX2,   
 ↓TPR, ↑TWIST1, ↓UPF3B, ↓WDR5, ↓ZNF423   
    
5 ↓ATAD3A, ↓BCAT1, ↑BMP4, ↓C1ORF24, 8 Cellular development, 
 ↓CDCA7, ↓CSDE1, ↓DDX18, ↓DKK1, ↑E2F4,   
 ↑FGF10, ↑FRAP1, ↑GATA1, ↑GATA2, ↓H2AFZ,  Gene expression, 
 ↓ID1, ↑ID2, ↑ID3, ↓IGF1, ↓LEF1, ↓MAX, ↓MINA,   
 ↓MRPL12, ↓MTHFD1, ↓MYC, ↓NCAM1, ↓NFYC,  Cell cycle 
 ↓NOG, ↑PABPC1, ↑PERP, ↓PSAT1, ↓PYCR2,   
 ↑SCEL, ↓SMARCA4, ↓WNT5A, ↓YME1L1   
    
a Bold and underlined genes are confirmed by the real-time RT-PCR.  






Table 2. Primer sequences used for RT-PCR and real-time RT-PCR 
 
Gene (NCBI ID)  Sequence 
  
Involucrin (NM_005547.2)  
Forward primer 5’-GGCCACCCAAACATAAATAACCAC-3’ 
Reverse primer 5’-CACCTAGCGGACCCGAAATAAGT-3’ 
  
Transglutaminase (NM_000359.2)  
Forward primer 5’-CACATCCCTTACCATGGACATCTAC-3’ 
Reverse primer 5’-GCAGTCGTTCCACACATGGA-3’ 
  
p16INK4A (NM_000077.4)  
Forward primer 5’-CTCCGGAAGCTGTCGACTTC-3’ 
Reverse primer 5’-TTCTGCCATTTGCTAGCAGTGT-3’ 
  
GAPDH (NM_002046.4)  
Forward primer 5’-CCATCTTCCAGGAGCGAGATC-3’ 










Table 3. Primer sequences used in network 1 for real-time RT-PCR 
 
Gene (NCBI ID) Sequences 
  
ANGPTL4 (NM_139314.1)  
Forward primer 5’-GAAAGAGGCTGCCCGAGATGG-3’ 
Reverse primer 5’-GGAGACCCCTGAGGCTGGATTT-3’ 
  
CEBPG (NM_001252296.1)  
Forward primer 5’-TTGGCAGCTTAGCGTGGAA-3’ 
Reverse primer 5’-TTGCTGCGATATCTTGCTCATT-3’ 
  
DCN (NM_001920.3)  
Forward primer 5’-GGTGTCAGCCGGATTGTGTTCA-3’ 
Reverse primer 5’-AGGGGGTAGGTGCTGCTCTGTG-3’ 
  
DDIT3 (NM_004083.5)  
Forward primer 5’-GGAGCATCAGTCCCCCACTT-3’ 
Reverse primer 5’-GTGGGATTGAGGGTCACATCA-3’ 
  
FST (NM_006350.3)  
Forward primer 5’-GCGGGCTGGATGGGAAAAC-3’ 
Reverse primer 5’-ACACATGTGGAGCTGCCTGGAC-3’ 
  
IL1β (NM_000576.2)  
Forward primer 5’-GGCAGGCCGCGTCAGTTC-3’ 
Reverse primer 5’-AAGGGAAAGAAGGTGCTCAGGTCA-3’ 
  
INHBA (NM_002192.2)  
Forward primer 5’-AAAAGAAGGGCGGAGGTGAAGG-3’ 
Reverse primer 5’-CCGGCGATGAGGGTGGTCT-3’ 
  
KLF11 (NM_003597.4)  





Reverse primer 5’-AAGCTGTGCTCTGGTGGAGTTT-3’ 
  
MMP3 (NM_002422.3)  
Forward primer 5’-TACAAGGAGGCAGGCAAGACAGC-3’ 
Reverse primer 5’-GCCACGCACAGCAACAGTAGGA-3’ 
  
PGF (NM_002632.5)  
Forward primer 5’-GGCCTTGTCTGCTGGGAACG-3’ 
Reverse primer 5’-CGCTGGGGTACTCGGACACG-3’ 
  
S100A8 (NM_002964.4)  
Forward primer 5’-CTATCATCGACGTCTACCACAAGTACT-3’ 
Reverse primer 5’-TGAGGACACTCGGTCTCTAGCA-3’ 
  
  
S100A9 (NM_002965.3)  
Forward primer 5’-GGACACAAATGCAGACAAGCA-3’ 
Reverse primer 5’-CTCGTCACCCTCGTGCATCT-3’ 
  
SOD2 (NM_000636.2)  
Forward primer 5’-GCGCCCTGGAACCTCACATC-3’ 
Reverse primer 5’-CAACGCCTCCTGGTACTTCTCCTC-3’ 
  
HPRT1 (NM_000184.2)  
Forward primer 5’-GGTCAGGCAGTATAATCCAAAGA-3’ 
Reverse primer 5’-GGGCATATCCTACAACAAACT-3’ 
  






Table 4. Primer sequences used in network 2 for real-time RT-PCR 
 
Gene (NCBI ID) Sequences 
  
S100A4 (NM_002961.2)   
Forward primer 5’-GAAGGCCCTGGATGTGATGGTGTC-3’ 
Reverse primer 5’-CTCCCGGGTCAGCAGCTCCTTTAG-3’ 
  
ITGA2 (NM_002203.3)  
Forward primer 5’-AACGGGACTTTCGCATCATC-3’ 
Reverse primer 5’-TACTTCGGCTTTCTCATCAGGTTT-3’ 
  
VEGF (AF_022375.1)  
Forward primer 5’-ACGCTGCCGCCACCACACC-3’ 
Reverse primer 5’-TCTCGCCCTCCGGACCCAAAGT-3’ 
  
CTGF (NM_001901.2)  
Forward primer 5’-GGCCCAGACCCAACTATGAT-3’ 
Reverse primer 5’-AGGCGGCTCTGCTTCTCTA-3’ 
  
VEGFB (NM_001243733.1)  
Forward primer 5’-CTCTAGGACCTGGGCCTCTCA-3’ 
Reverse primer 5’-CTGCCTCCCAGTCTCCTCTTC-3’ 
  
DDR1 (NM_013993.2)  
Forward primer 5’-TGCGCTATCTGGCCACACTCAACT-3’ 
Reverse primer 5’-CGGCCCTGCACACGGTAATAG-3’ 
  
CYR61 (NM_001554.4)  
Forward primer 5’-ACGGCTGCGGCTGCTGTAAGGTCT-3’ 
Reverse primer 5’-GTGGAGCTGGCGCCGAAGTTGC-3’ 
  
TIMP2 (NM_003255.4)  





Reverse primer 5’-CCGAGGAGGGGGCCGTGTAGATA-3’ 
  
MMP1 (NM_002421.3)  
Forward primer 5’-ATTCTACTGATATCGGGGCTTTGA-3’ 
Reverse primer 5’-GATGGGCTGGACAGGATTTTG-3’ 
  
MMP14 (NM_004995.2)  
Forward primer 5’-GGCCCGCCCACTCCTACCACAAG-3’ 
Reverse primer 5’-AAGGAGGCCAGCCAGGGGACAGAG-3’ 
  
HPRT1 (NM_000184.2)  
Forward primer 5’-GGTCAGGCAGTATAATCCAAAGA-3’ 
Reverse primer 5’-GGGCATATCCTACAACAAACT-3’ 
  






Table 5. Primer sequences used in network 3 for real-time RT-PCR 
 
Gene (NCBI ID) Sequences 
  
AREG (NM_001657.2)  
Forward primer 5’-CCCGGTCTCCACTCGCTCTTC-3’ 
Reverse primer 5’-CGGGGCTCTCATTGGTCCTTC-3’ 
  
EREG (NM_001432.2)  
Forward primer 5’-CTGTGGAGGCTGAGATGAAAACT-3’ 
Reverse primer 5’-TGCAATAGCCCAAAAATACTCCT-3’ 
  
IL8 (NM_000584.3)  
Forward primer 5’-TCAGAGACAGCAGAGCACACAA-3’ 
Reverse primer 5’-GGCCAGCTTGGAAGTCATGT-3’ 
  
MMP9 (NM_004994.2)  
Forward primer 5’-GGCACCACCACAACATCACCTATT-3’ 
Reverse primer 5’-CGTCACCGCGCTCCACAGT-3’ 
  
NRG1 (NM_013964.3)  
Forward primer 5’-CCTTGCCTCCCCGATTGA-3’ 
Reverse primer 5’-TCCCATTCTTGAACCACTTGA-3’ 
  
PTGS2 (NM_000963.2)  
Forward primer 5’-CAGCCAGACGCCCTCAGACAG-3’ 
Reverse primer 5’-ATGGGTGGGAACAGCAAGGATTT-3’ 
  
SPRY2 (NM_005842.2)  
Forward primer 5’-TGCACGCCTACAGGTGTGA-3’ 
Reverse primer 5’-AGGCACTGCTTGTCGCAGAT-3’ 
  
HPRT1 (NM_000184.2)  
Forward primer 5’-GGTCAGGCAGTATAATCCAAAGA-3’ 
Reverse primer 5’-GGGCATATCCTACAACAAACT-3’ 
  






Table 6. Primer sequences used in network 4 for real-time RT-PCR 
 
Gene (NCBI ID) Sequences 
  
NUP98 (NM_016320.4)  
Forward primer 5’-GCTTTGACAGATCCAAATGCTTCT-3’ 
Reverse primer 5’-GATTCCGGAAGAGAGGAGAGTCT-3’ 
  
TGM1 (NM_000359.2)  
Forward primer 5’-AGACTCCCGCCGGCCTGTATCC-3’ 
Reverse primer 5’-GGTGCTCTCGGCGGTTCTGGTC-3’ 
  
NFATC3 (NM_173165.2)  
  Forward primer 5’-GCCACACCCCTATATTTCGCACAT-3’ 
  Reverse primer 5’-CCCCTCGGCTACCTTCAGTTTCAT-3’ 
  
SOX9 (NM_000346.3)  
  Forward primer 5’-GGCCAGTCCCAGCGAACG-3’ 
  Reverse primer 5’-GAGCGGGTGATGGGCGGGTAGG-3’ 
  
BMP2 (NM_001200.2)  
  Forward primer 5’-CCCCACGGAGGAGTTTATCACC-3’ 
  Reverse primer 5’-ACGGGGAATTTCGAGTTGGCTGTT-3’ 
  
BHLHB2 (NM_003670.2)  
  Forward primer 5’-GGCCCACACCCACACCAG-3’ 
  Reverse primer 5’-TGCGGCAGAGGCGTTGAG-3’ 
  
HES1 (NM_005524.3)  
  Forward primer 5’-CAGGCTGGAGAGGCGGCTAAGGTG-3’ 







SMAD1 (NM_005900.2)  
  Forward primer 5’-GATACGCCCCCACCTGCTTACCTG-3’ 
  Reverse primer 5’-GCAACCGCCTGAACATCTCCTCTG-3’ 
  
PCAF (NM_003884.4)  
  Forward primer 5’-TGGCCGTGTTATTGGTGGTA-3’ 
  Reverse primer 5’-GCCCTTGACTTGCTCATTTGA-3’ 
  
FOXG1B (NM_005249.4)  
  Forward primer 5’-CGGCTCACGCTCAACGGCATCTAC-3’ 
  Reverse primer 5’-TGGCGCGGCACCTTCACGA-3’ 
  
TWIST1 (NM_000474.3)  
  Forward primer 5’-CAGCGGCACCATCCTCACACCTCT-3’ 
  Reverse primer 5’-TGGCTGATTGGCACGACCTCTTGA-3’ 
  
ID3 (NM_002167.4)  
  Forward primer 5’-AGCTCGCTCCGGAACTTGTCATC-3’ 
  Reverse primer 5’-TCCCGGGGTCCCAGGCAGAAC-3’ 
  
HPRT1 (NM_000184.2)  
  Forward primer 5’-GGTCAGGCAGTATAATCCAAAGA-3’ 
  Reverse primer 5’-GGGCATATCCTACAACAAACTC-3’ 
  






Table 7. Primer sequences used in network 5 for real-time RT-PCR 
 
Gene (NCBI ID) Sequences 
  
BMP4 (NM_001202.3)  
  Forward primer 5’-TCACAGCGGGCCAGGAAGAAGAAT-3’ 
  Reverse primer 5’-GGCAGTCCCCATGGCAGTAGAAGG-3’ 
  
ID3 (NM_002167.4)  
  Forward primer 5’-AGCTCGCTCCGGAACTTGTCATC-3’ 
  Reverse primer 5’-TCCCGGGGTCCCAGGCAGAAC-3’ 
  
MYC (NM_002467.4)  
  Forward primer 5’-CGACGCGGGGAGGCTATTCTGC-3’ 
  Reverse primer 5’-ATCGTCGCGGGAGGCTGCTGGTTT-3’ 
  
SMARCA4 (NM_003072.3)  
  Forward primer 5’-AAGGGCAAAGGCGGCACCAAGACC-3’ 
  Reverse primer 5’-AATGCCGCCAGTGAACCCCAAGTG-3’ 
  
SCEL (NM_144777.2)  
  Forward primer 5’-CACTTACTGCCGAAAACC-3’ 
  Reverse primer 5’-TCACCCGCTTGTAGATT-3’ 
  
FGF10 (NM_004465.1)  
  Forward primer 5’-TCACCAGAGGCCACCAACTC-3’ 
  Reverse primer 5’-AGCGGACATCTCCTTGAAGGT-3’ 
  
DKK1 (NM_012242.2)  
  Forward primer 5’-CCGGGTCTTTGTCGCGATGGTAGC-3’ 
  Reverse primer 5’-AGCGGTGGGGGCAGGTTCTTGAT-3’ 
  
E2F4 (NM_001950.3)  





  Reverse primer 5’-CGAAGGCCGCAGAAAGGGAGAA-3’ 
  
NOG (NM_005450.4)  
  Forward primer 5’-GCCCGGCACCCAGCGACAAC-3’ 
  Reverse primer 5’-CGTAGTGGCCCCCGAGCAG-3’ 
  
ID1 (NM_181353.2)  
  Forward primer 5’-CGACATGAACGGCTGTTACTCA-3’ 
  Reverse primer 5’-GTCGATGACGTGCTGGAGAA-3’ 
  
HPRT1 (NM_000184.2)  
  Forward primer 5’-GGTCAGGCAGTATAATCCAAAGA-3’ 
  Reverse primer 5’-GGGCATATCCTACAACAAACT-3’ 
  






Table 8. Primer sequences used for analysis of inflammatory genes after IL-1β treatment in 
real-time RT-PCR 
 
Gene (NCBI ID) Sequences 
  
IL-1β (NM_000576.2)  
  Forward primer 5'-GGCAGGCCGCGTCAGTTC-3' 
  Reverse primer 5'-AAGGGAAAGAAGGTGCTCAGGTCA-3' 
  
S100A8 (NM_002964.4)  
  Forward primer 5'-CTATCATCGACGTCTACCACAAGTACT-3' 
  Reverse primer 5'-TGAGGACACTCGGTCTCTAGCA-3' 
  
S100A9 (NM_002965.3)  
  Forward primer 5'-GGACACAAATGCAGACAAGCA-3' 
  Reverse primer 5'-CTCGTCACCCTCGTGCATCT-3' 
  
MMP1 (NM_002421.3)  
  Forward primer 5'-ATTCTACTGATATCGGGGCTTTGA-3' 
  Reverse primer 5'-GATGGGCTGGACAGGATTTTG-3' 
  
MMP9 (NM_004994.2)  
  Forward primer 5'-GGCACCACCACAACATCACCTATT-3' 
  Reverse primer 5'-CGTCACCGCGCTCCACAGT-3' 
  
VEGF (AF_022375.1)  
  Forward primer 5'-ACGCTGCCGCCACCACACC-3' 
  Reverse primer 5'-TCTCGCCCTCCGGACCCAAAGT-3' 
  
IL-8 (NM_000584.3)  
  Forward primer 5'-TCAGAGACAGCAGAGCACACAA-3' 
  Reverse primer 5'-GGCCAGCTTGGAAGTCATGT-3' 
  
HPRT1 (NM_000184.2)  
  Forward primer 5'-GGTCAGGCAGTATAATCCAAAGA-3' 
  Reverse primer 5'-GGGCATATCCTACAACAAACT-3' 
  






Table 9. The abbreviation of genes 
Symbol Description 
  
Network 1  
ANGPTL4 Angiopoietin-related protein 4 
CEBPG CCAAT/enhancer-binding protein gamma 
DCN Decorin 
DDIT3 DNA damage-inducible transcript 3 
FST Follistatin 
IL-1B Interleukin-1 beta 
INHBA Inhibin, beta A 
KLF11 Krueppel-like factor 11 
MMP3 Matrix Metalloproteinase-3 
PGF Placental growth factor 
S100A8 S100 Calcium Binding Protein A8 
S100A9 S100 calcium binding protein A9 
SOD2 Superoxide dismutase 2 
  
Network 2  
ITGA2 Integrin, alpha 2 
CTGF Connective tissue growth factor 
VEGF Vascular endothelial growth factor 
CYR61 Cysteine-rich angiogenic inducer 61 
MMP1 Matrix metalloproteinase-1 
MMP14 Matrix metalloproteinase-14 
S100A4 S100 calcium binding protein A4 
DDR1 Discoidin domain receptor tyrosine kinase 1 
TIMP2 TIMP metallopeptidase inhibitor 2 
VEGFB Vascular endothelial growth factor B 
  








MMP9 Matrix Metalloproteinase-9 
NRG1 Neuregulin 1 
PTGS2 Prostaglandin-endoperoxide synthase 2 
SPRY2 Sprouty homolog 2 
  
Network 4  
BHLHB2 Basic helix-loop-helix B2 
ID3 Inhibitor of DNA binding 3 
BMP2 Bone morphogenetic protein 2 
FOXG1B Forkhead box protein G1 
HES1 Hairy and enhancer of split-1 
NFATC3 Nuclear factor of activated T-cells, cytoplasmic 3 
SMAD1 SMAD family member 1 
SOX9 SRY (sex determining region Y)-box 9 
TGM1 Transglutaminase-1 
TWIST1 Twist-related protein 1 
NUP98 Nuclear pore complex protein 
PCAF P300/CBP-associated factor 
  
Network 5  
BMP4 Bone morphogenetic protein 4 
E2F4 E2F transcription factor 4 
DKK1 Dickkopf-related protein 1 
ID3 Inhibitor of DNA binding 3 
FGF10 Fibroblast growth factor 10 
SCEL Sciellin 
SMARCA4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, 
subfamily a, member 4 
MYC v-myc myelocytomatosis viral oncogene homolog 
NOG Noggin 
ID1 Inhibitor of DNA binding 
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Table 10. Upregulated and downregulated genes in human oral keratinocytes in response 
to serial subculture (DNA microarray) 
 
UPREGULATED GENES 
 Gene ontology/genes                      Symbol         GeneBank ID  Fold change 
    
Cell growth    
epithelial membrane protein1 EMP1 NM_001423 6.2 
Kruppel-like factor 6 KLF6 NM_001300 2.9 
    
Cell cycle    
interleukin 8 IL8 NM_000584   14.6 
p16 CDKN2A NM_000077 9.8 
cyclin G2 CCNG2 NM_004354 5.6 
p57 DCKN1C NM_000076 4.5 
retinoblastoma 1 RB1 NM_000321 3.6 
cyclin D1 CCND1 NM_053056 3.4 
p15 CDKN2B NM_004936 3.4 
dual specificity phosphatase 1 DUSP1 NM_004417 3.1 
p19 CDKN2D NM_001800 2.6 
    
Cell death    
interleukin 6 IL6 NM_000600  4.3 
interleukin 1, beta  IL1B NM_000576 3.0 
tumor necrosis factor TNF NM_000594  2.8 
    
Growth factor activity    
fibroblast growth factor 5 FGF5 NM_004464   15.7 
chemokine(C-X-C motif) ligand 12 CXCL12 NM_000609 7.2 
bone morphogenetic protein 6 BMP6 NM_001718 6.1 
chemokine(C-X-C motif) ligand 1 CXCL1 NM_001511 5.8 
bone morphogenetic protein 2 BMP2 NM_001200 2.3 
    
Cell adhesion    
intercellular adhesion molecule 1 ICAM1 NM_000201   162.9 
periostin POSTN NM_006475   30.5 
chemokine(C-C motif) ligand 5 CCL5 NM_002985   27.8 
fibronectin 1 FN1 NM_002026   23.6 
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versican VCAN NM_004385   19.7 
claudin 1 CLDN1 NM_021101   11.7 
connective tissue growth factor CTGF NM_001901   11.4 
collagen, type VI, alpha 2 COL6A2 NM_00184   9.8 
claudin 4 CLDN4 NM_001305   7.4 
 
Cell surface receptor linked signaling pathway   
paired box gene 8 PAX8 NM_003466   50.2 
toll-like receptor 2  TLR2 NM_003264    22.9 
transforming growth factor beta receptor I TGF-β1 NM_004612 8.0 
defensin, beta 1 DEFB1 NM_005218 7.3 
chemokine(C-X-C motif) ligand 10 CXCL10 NM_001565  6.4 
bone morphogenetic protein 6 BMP6 NM_001718  6.1 
chemokine(C-X-C motif) ligand 1 CXCL1 NM_001511 5.8 
interleukin 6 IL6 NM_000600 4.3 
signal transducer and activator of 
transcription 4 STAT4 NM_003151 2.8 
    
Intracellular signaling pathway    
dual specificity phosphatase 10 DUSP10 NM_007207   17.9 
interleukin 8 IL8 NM_000584   14.6 
chemokine(C-X-C motif) ligand 1 CXCL1 NM_001511 5.8 
interleukin-1 receptor-associated kinase 2 IRAK2 NM_001570 4.1 
toll-like receptor 1  TLR1 NM_003263  3.8 
cyclin D1 CCND1 NM_053056 3.4 
dual specificity phosphatase 6 DUSP6 NM_001946  2.1 
    
Cytokine activity    
interleukin 33 IL33 NM_033439    44.0 
chemokine(C-X-C motif) ligand 5 CXCL5 NM_002994   29.7 
chemokine(C-C motif) ligand 5 CCL5 NM_002985   27.8 
interleukin 8 IL8 NM_000584   14.6 
chemokine(C-X-C motif) ligand 12 CXCL12 NM_000609 7.2 
chemokine(C-X-C motif) ligand 10 CXCL10 NM_001565 6.4 
bone morphogenetic protein 6 BMP6 NM_001718 6.1 
chemokine(C-X-C motif) ligand 1 CXCL1 NM_001511 5.8 
chemokine(C-X-C motif) ligand 14 CXCL14 NM_004887 5.7 
interleukin 32 IL32 NM_004221 4.6 
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interleukin 6 IL6 NM_000600 4.3 
chemokine(C-C motif) ligand 27 CCL27 NM_006664 3.2 
chemokine(C-C motif) ligand 20 CCL20 NM_004591 3.1 
interleukin 24 IL24 NM_006850 2.8 
tumor necrosis factor TNF NM_000594 2.8 
interleukin 20 IL20 NM_018724 2.8 
chemokine(C-X-C motif) ligand 11 CXCL11 NM_005409 2.5 
bone morphogenetic protein 2 BMP2 NM_001200    2.2 
chemokine(C-X-C motif) ligand 2 CXCL2 NM_002089     2.1 
    
Proteolysis    
matrix metallopeptidase 12 MMP12 NM_002426   36.7 
matrix metallopeptidase 10 MMP10 NM_002425    7.5 
kallikrein-related peptidase 7 KLK7 NM_005046    7.0 
matrix metallopeptidase 9 MMP9 NM_004994    4.8 
matrix metallopeptidase 3 MMP3 NM_002422    4.7 
cathepsin S CTSS NM_004079    4.2 
plasminogen activator urokinase PLAU NM_002658    4.1 
matrix metallopeptidase 1 MMP1 NM_002421    4.0 
kallikrein-related peptidase 13 KLK13 NM_015596    3.7 
matrix metallopeptidase 28 MMP28 NM_024302    3.7 
matrix metallopeptidase 14 MMP14 NM_004995    3.6 
cathepsin L2 CTSL2 NM_001333     3.5 
kallikrein-related peptidase 8 KLK8 NM_007196    3.3 
cathepsin B CTSB NM_001908    3.3 
matrix metallopeptidase 2 MMP2 NM_004530    2.9 
cathepsin H CTSH NM_004390    2.8 
cathepsin F CTSF NM_003793    2.6 
 
Apoptosis    
cyclin-dependent kinase inhibitor 2A CDKN2A NM_000077    9.8 
interleukin 6 IL6 NM_000600     4.3 
interleukin 1, beta  IL1B NM_000576    3.0 
interleukin 24 IL24 NM_006850    2.8 
    
Response to stress    
S100 calcium binding protein A7 S100A7 NM_002963  181.7 
chemokine(C-X-C motif) ligand 5 CXCL5 NM_002994   29.7 
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chemokine(C-C motif) ligand 5 CCL5 NM_002985     27.8 
fibronectin 1 FN1 NM_002026   23.6 
toll-like receptor 2  TLR2 NM_003264   22.9 
dual specificity phosphatase 10 DUSP10 NM_007207   17.9 
interleukin 8 IL8 NM_000584   14.6 
S100 calcium binding protein A12 S100A12 NM_005621     9.7 
defensin, beta 1 DEFB1 NM_005218    7.3 
chemokine(C-X-C motif) ligand 12 CXCL12 NM_000609    7.2 
chemokine(C-X-C motif) ligand 10 CXCL10 NM_001565    6.4 
S100 calcium binding protein A9 S100A9 NM_002965    6.2 
chemokine(C-X-C motif) ligand 1 CXCL1 NM_001511    5.8 
defensin, beta 4 DEFB4 NM_004942     5.8 
chemokine(C-X-C motif) ligand 14 CXCL14 NM_004887    5.7 
interleukin 6 IL6 NM_000600    4.3 
superoxide dismutase 2, mitochondrial SOD2 NM_000636     3.9 
toll-like receptor 1  TLR1 NM_003263     3.8 
S100 calcium binding protein A8 S100A8 NM_002964    3.4 
chemokine(C-C motif) ligand 20 CCL20 NM_004591     3.1 
dual specificity phosphatase 1 DUSP1 NM_004417    3.1 
interleukin 1, beta  IL1B NM_000576    3.0 
heat shock 27kDa protein 1 HSPB1 NM_001540    2.8 
chemokine(C-X-C motif) ligand 11 CXCL11 NM_005409     2.5 
chemokine(C-X-C motif) ligand 2 CXCL2 NM_002089    2.1 
    
Inflammatory response    
chemokine(C-X-C motif) ligand 5 CXCL5 NM_002994   29.7 
chemokine(C-C motif) ligand 5 CCL5 NM_002985   27.8 
toll-like receptor 2  TLR2 NM_003264   22.9 
interleukin 8 IL8 NM_000584   14.6 
S100 calcium binding protein A12 S100A12 NM_005621    9.7 
chemokine(C-X-C motif) ligand 12 CXCL12 NM_000609    7.2 
chemokine(C-X-C motif) ligand 10 CXCL10 NM_001565    6.4 
S100 calcium binding protein A9 S100A9 NM_002965     6.2 
chemokine(C-X-C motif) ligand 1 CXCL1 NM_001511    5.8 
chemokine(C-X-C motif) ligand 14 CXCL14 NM_004887     5.7 
interleukin 6 (interferon, beta 2) IL6 NM_000600    4.3 
toll-like receptor 1  TLR1 NM_003263    3.8 
S100 calcium binding protein A8 S100A8 NM_002964    3.4 
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chemokine(C-C motif) ligand 20 CCL20 NM_004591    3.1 
interleukin 1, beta  IL1B NM_000576    3.0 
chemokine(C-X-C motif) ligand 11 CXCL11 NM_005409    2.5 
chemokine(C-X-C motif) ligand 2 CXCL2 NM_002089    2.1 
chemokine(C-C motif) receptor 2 CCL2 NM_000647    2.0 
    
Immune response    
S100 calcium binding protein A7 S100A7 NM_002963  181.7 
chemokine(C-X-C motif) ligand 5 CXCL5 NM_002994   29.7 
chemokine (C-C motif) ligand 5 CCL5 NM_002985   27.8 
toll-like receptor 2  TLR2 NM_003264   22.9 
interleukin 8 IL8 NM_000584   14.6 
defensin, beta 1 DEFB1 NM_005218    7.3 
chemokine(C-X-C motif) ligand 12 CXCL12 NM_000609    7.2 
chemokine(C-X-C motif) ligand 10 CXCL10 NM_001565    6.4 
chemokine(C-X-C motif) ligand 1 CXCL1 NM_001511    5.8 
defensin, beta 4  DEFB4 NM_004942     5.8 
chemokine(C-X-C motif) ligand 14 CXCL14 NM_004887     5.7 
interleukin 6 (interferon, beta 2) IL6 NM_000600    4.3 
toll-like receptor 1  TLR1 NM_003263     3.8 
chemokine (C-C motif) ligand 27 CCL27 NM_006664     3.2 
chemokine (C-C motif) ligand 20 CCL20 NM_004591    3.1 
interleukin 1, beta  IL1B NM_000576     3.0 
    
Multicellular organismal development  
S100 calcium binding protein A7 S100A7 NM_002963  181.7 
Decorin  DCN NM_001920   59.3 
paired box gene 8 PAX8 NM_003466   50.2 
cystatin E/M  CST6 NM_001323    19.7 
versican VCAN NM_004385   19.7 
paired box gene 4 PAX4 NM_006193   17.2 
fibroblast growth factor 5 FGF5 NM_004464    15.7 
periostin POSTN NM_006475   12.2 
S100 calcium binding protein A4 S100A4 NM_002961   11.3 
Cbp/p300-interacting transactivator CITED2 NM_006079   11.3 
chemokine(C-X-C motif) ligand 10 CXCL10 NM_001565     6.4 
runt-related transcription factor 1 RUNX1 NM_001754     5.6 
hairy and enhancer of split 1 HES1 NM_005524     5.3 
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pim-1 oncogene  PIM1 NM_002648     4.7 
early growth response 3 EGR3 NM_004430      4.1 
SRY(sex determining region Y)-box 9 SOX9 NM_000346     3.7 
inhibitor of DNA binding 3 ID3 NM_002167    3.0 
high-mobility group box 3 HMGB3 NM_005342    3.0 
SRY(sex determining region Y)-box 4 SOX4 NM_003107      2.6 
frizzled homolog 7 FZD7 NM_003507      2.4 
twist homolog 1  TWIST1 NM_000474    2.2 
transglutaminase 1 TGM1 NM_000359    2.1 










Table 10. Upregulated and downregulated genes in human oral keratinocytes in response 
to serial subculture (DNA microarray) 
 
DOWNREGULATED GENES 
 Gene ontology/genes                         Symbol     GeneBank ID  Fold change 
    
Cell cycle    
cell division cycle 20 CDC20 NM_001255     0.03 
cyclin dependent kinase inhibitor 3 CDKN3 NM_005192     0.04 
cell division cycle 6 CDC6 NM_001254     0.04 
cell division cycle 20B CDC20B NM_152623     0.04 
cyclin B2  CCNB2 NM_004701     0.05 
DNA damage inducible transcript 3 DDIT3 NM_004083     0.06 
baculoviral IAP repeat containing 5 BIRC5 NM_001168     0.07 
cell division cycle 25C CDC25C NM_001790     0.08 
cyclin A2 CCNA2 NM_001237     0.08 
cell division cycle 2 CDC2 NM_001786     0.2 
BRCA1, DNA repair associated BRCA1 NM_007294     0.2 
aurora kinase B  AURKB NM_004217     0.2 
RAD51 recombinase RAD51 NM_002875     0.3 
mutL homolog 1 MLH1 NM_000249     0.3 
checkpoint kinase 1 CHEK1 NM_001274     0.4 
    
Cell death    
baculoviral IAP repeat containing 5 BIRC5 NM_001168     0.01 
Interferon beta 1 IFNB1 NM_002176     0.07 
BCL2, apoptosis regulator BCL2 NM_000633     0.5 
    
Growth factor activity    
neuregulin 1 NRG1  NM_004495     0.08 
fibroblast growth factor 23  FGF23 NM_020638     0.1 
platelet derived growth factor subunit A PDGFA NM_002607     0.1 
vascular endothelial growth factor A VEGFA NM_003376     0.3 
brain derived neurotrophic factor BDNF NM_001709    0.3 
fibroblast growth factor FGF2 NM_002006     0.4 
vascular endothelial growth factor B VEGFB NM_003377     0.5 
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Cell adhesion    
collagen type XXI alpha 1 chain COL21A1 NM_030820     0.05 
C-C motif chemokine receptor 1 CCR1 NM_001295    0.2 
tenascin C TNC NM_002160    0.2 
collagen type XVIII alpha 1 chain COL18A1 NM_030582    0.2 
collagen type XII alpha 1 chain COL12A1 NM_004370     0.3 
claudin 19  CLDN19 NM_148960     0.3 
claudin 8 CLDN8 NM_012132     0.3 
periostin POSTN NM_006475    0.4 
claudin 7 CLDN7 NM_001307    0.5 
    
Cell surface receptor linked signaling pathway 
platelet derived growth factor subunit A PDGFA NM_002607     0.1 
C-C motif chemokine receptor 1  CCR1 NM_001295     0.2 
fibroblast growth factor receptor 4  FGFR4 NM_002011     0.4 
epiregulin EREG NM_001432     0.5 
    
Intracellular signaling pathway    
DNA damage inducible transcript 3 DDIT3 NM_004083    0.06 
C-C motif chemokine receptor 1 CCR1 NM_001295    0.2 
neuregulin 1 NRG1  NM_004495     0.2 
high mobility group box 2 HMGB2  NM_002129     0.2 
BRCA1, DNA repair associated BRCA1 NM_007294     0.2 
proliferating cell nuclear antigen PCNA NM_002592    0.3 
checkpoint kinase 1 CHEK1  NM_001274     0.4 
fibroblast growth factor 2 FGF2 NM_002006     0.4 
    
Cytokine activity    
TNF superfamily member 15 TNFSF15 NM_005118     0.06 
pleiotrophin PTN NM_002825     0.4 
growth differentiation factor 15 GDF15 NM_004864     0.4 
CKLF like MARVEL transmembrane domain 
containing 4  
CMTM4 NM_178818     0.4 
Small inducible cytokine subfamily E, member 1 SCYE1 NM_004757     0.5 
TNF superfamily member 13 TNFSF13 NM_003808     0.5 
    
Signal transduction    
hyaluronan mediated motility receptor HMMR NM_012484     0.01 
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cell division cycle 6 CDC6 NM_001254     0.04 
BRCA2, DNA repair associated BRCA2 NM_000059     0.06 
cyclin A2 CCNA2 NM_001237     0.08 
BUB1 mitotic checkpoint serine/threonine kinase BUB1 NM_004336     0.08 
calcium/calmodulin dependent protein kinase I CAMK1 NM_003656     0.1 
period circadian clock 2 PER2 NM_003894     0.1 
C-C motif chemokine receptor 1  CCR1 NM_001295     0.2 
high mobility group box 2 HMGB2 NM_002129     0.2 
fibroblast growth factor binding protein 1  FGFBP1 NM_005130     0.2 
proliferating cell nuclear antigen PCNA NM_002592     0.3 
vascular endothelial growth factor A  VEGFA NM_003376     0.3 
cryptochrome circadian clock 1 CRY1 NM_004075     0.3 
checkpoint kinase 1  CHEK1 NM_001274     0.4 
high mobility group box 1 HMGB1 NM_002128     0.5 
period circadian clock 3 PER3 NM_016831     0.5 
    
Proteolysis    
caspase 9 CASP9  NM_001229     0.5 
    
Apoptosis    
baculoviral IAP repeat containing 5 BIRC5 NM_001168     0.01 
BUB1 mitotic checkpoint serine/threonine kinase B BUB1B  NM_001211     0.04 
interferon beta 1  IFNB1 NM_002176     0.07 
caspase 9 CASP9  NM_001229     0.5 
cytochrome c, somatic CYCS NM_018947     0.5 
    
Response to stress    
BRCA2, DNA repair associated BRCA2  NM_000059     0.06 
cyclin A2 CCNA2 NM_001237     0.08 
C-C motif chemokine receptor 1 CCR1 NM_001295     0.2 
high mobility group box 2 HMGB2  NM_002129     0.2 
BRCA1, DNA repair associated BRCA1 NM_007294     0.2 
mutL homolog 1 MLH1 NM_000249     0.3 
proliferating cell nuclear antigen PCNA NM_002592     0.3 
vascular endothelial growth factor A VEGFA  NM_003376     0.3 
ATM serine/threonine kinase ATM NM_000051     0.4 
sterol regulatory element binding transcription 
factor 1 
SREBF1 NM_004176     0.4 
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CCAAT/enhancer binding protein gamma CEBPG NM_001806     0.4 
checkpoint kinase 1 CHEK1 NM_001274     0.4 
RAD51 recombinase RAD51 NM_002875     0.4 
mitogen-activated protein kinase kinase kinase 
kinase 2 
MAP4K2 NM_004579     0.4 
high mobility group box 1 HMGB1 NM_002128     0.5 
epiregulin EREG NM_001432     0.5 
BCL2, apoptosis regulator BCL2 NM_000633     0.5 
ATR serine/threonine kinase ATR NM_001184     0.5 
RAD50 double strand break repair protein RAD50  NM_005732     0.5 
    
Inflammatory response    
C-C motif chemokine receptor 1 CCR1 NM_001295     0.2 
    
Immune response    
TNF superfamily member 15 TNFSF15 NM_005118 0.06 
C-C motif chemokine receptor 1 CCR1 NM_001295 0.2 
BCL2, apoptosis regulator BCL2 NM_000633     0.5 
    
Multicellular organismal development    
neuropilin 1 NRP1 NM_003873     0.05 
neuregulin 1 NRG1 NM_004495     0.08 
calcium/calmodulin dependent protein kinase I CAMK1 NM_003656     0.1 
frizzled class receptor 1 FZD1 NM_003505     0.1 
brain derived neurotrophic factor BDNF NM_001709     0.3 
SMAD family member 1 SMAD1 NM_005900     0.4 
homeobox A7 HOXA7 NM_006896     0.4 
homeobox A6 HOXA6 NM_024014     0.4 
hes family bHLH transcription factor 7 HES7 NM_032580     0.4 
fibroblast growth factor 2 FGF2 NM_002006     0.4 
msh homeobox 2 MSX2 NM_002449     0.4 
periostin POSTN NM_006475     0.4 
ATR serine/threonine kinase ATR NM_001184     0.5 















Figure 3. Cellular replication of serial subculture primary normal human oral keratinocytes 
(NHOKs) in vitro. (a) Microscopic features of NHOKs with increasing PDs. Scale bar is 100 μm. 















































































Figure 4. Differentiation associated gene expression in NHOKs with different PDs. (a) Levels 
of involucrin and transglutaminase proteins in NHOKs. β-actin served as a control for the 
differences in the staring amount of protein. (b and c) Expression of differentiation markers, 
including involucrin and transglutaminase, was measured by RT-PCR (b) and real-time PCR (c) 
analysis. RT-PCR for GAPDH was used as a loading control, and a reaction without input nucleic 






















































































Figure 5. Senescence associated gene expression in NHOKs with different PDs. (a) Western 
blot analysis of p16INK4A in NHOKs. (b and c) Expression of p16INK4A was measured by RT-PCR 
(b) and real-time PCR (c) analysis. Data are expressed as the mean ± SD (n = 3). (d) Microscopic 
features of the exponentially growing (PD 12.1) and terminally differentiated and replicative 
senescent (PD 18.1) NHOKs. (e) Phase-contrast micrographs of senescence-associated β-
galactosidase staining (SA-β-gal staining) of the exponentially growing (PD 14.1) and terminally 
differentiated and senescent (PD 21.6) NHOKs. The culture conditions were the same as 



























Figure 6. Cell cycle profile analysis. NHOKs (PD 10.0, 12.1 and 14.1) were submitted to flow 











Figure 7. An integrated network with both upregulated and downregulated genes in the 
exponentially growing (PD 14.1) and terminally differentiated and senescent (PD 21.6) 
NHOKs.  Dataset was analyzed by the Ingenuity Pathways Analysis software. The top scoring 
network of annotated genes significantly regulates by serial subculture at PD 21.6 relative to PD 






Figure 8a. Measurement of mRNA levels of some genes in network 1 by real-time RT-PCR 
during subculture-induced cell differentiation and senescence in NHOKs. Data are 






































Figure 8b. Measurement of mRNA levels of some genes in network 2 by real-time RT-PCR 
during subculture-induced cell differentiation and senescence in NHOKs. Data are expressed 







































Figure 8c. Measurement of mRNA levels of some genes in network 3 by real-time RT-PCR 
during subculture-induced cell differentiation and senescence in NHOKs. Data are expressed 
as mean ± SD (n = 3). *p < 0.01, **p < 0.05. 








Figure 8d. Measurement of mRNA levels of some genes in network 4 by real-time RT-PCR 
during subculture-induced cell differentiation and senescence in NHOKs. Data are expressed 







































Figure 8e. Measurement of mRNA levels of some genes in network 5 by real-time RT-PCR 
during subculture-induced cell differentiation and senescence in NHOKs. Data are expressed 





Figure 9a. Effects of IL-1β on the expression of inflammatory molecules in primary normal 
human oral keratinocytes (NHOKs). (a) Levels of IL-1β, S100A8, S100A9, IL-8, MMP1, 
MMP9, and VEGF mRNAs in NHOKs treated with IL-1β. Exponentially growing NHOKs were 
incubated with 10 ng/ml of recombinant human IL-1β for 12, 24, 48, 72, and 96 h. Total RNA 
was isolated and subjected to quantitative real-time PCR. Data are expressed as fold change over 










































Figure 9b. Effects of IL-1β/IL-1F2 on the expression of inflammatory molecules in primary 
human oral keratinocytes. (b) Levels of IL-1β, S100A9, MMP1, MMP9, and IL-8 mRNAs in 
terminally differentiating and senescent cells treated with IL-1β/IL-1F2 neutralizing antibody (10 






Figure 10a. H&E staining and immunohistochemical analysis of involucrin, p16INK4A in 
gingiva of young (3 months) and old (2 years) mice. 4 µm thick sections of formalin-fixed and 
paraffin-embedded mice gingival tissues were deparaffinized, and immunoreactivity was detected 







Figure 10b. H&E staining and immunohistochemical analysis of IL-1β, DEC1, and VEGF 
in gingiva of young (3 months) and old (2 years) mice. 4 µm thick sections of formalin-fixed 
and paraffin-embedded mice gingival tissues were deparaffinized, and immunoreactivity was 







사람 구강각화세포의 최종분화 및 복제노화 과정에서 
유전자 발현 프로파일링 
 
장 다 현 
 종양 및 발달 생물학 전공 
서울대학교 치의학대학원 
(지도교수: 민 병 무, D.D.S., M.S., Ph.D.) 
 
체세포(somatic cells)는 제한된 복제능력을 갖고 있으며, 일정 횟수의 세포분열 후 
텔로미어 단축(telomere shortening)에 의해 DNA 손상이 촉발됨으로서 더 이상 DNA 
복제를 하지 못하고 비가역적으로 세포분열 정지상태에 도달하는데 이를 
복제노화라고 한다. 또한 복제노화가 일어난 세포는 비록 대사활성은 유지하고 
있지만 형태학적 변화와 유전자 발현에 큰 차이를 보인다. 분화와 노화관련 




최종분화 및 복제노화 과정에서 관련유전자를 포괄적으로 분석하고, 그의 
네트워크와 주요기능 분석에 관한 연구는 아직 완전히 밝혀지지 않았다. 그러므로 
본 연구는 사람 정상 구강각화세포의 최종분화 및 복제노화 과정에서 이와 관련된 
유전자 발현변화를 포괄적으로 분석하고, 이들 유전자들의 네트워크와 기능의 
일단을 연구하였다. 사람 구강각화세포를 일차배양한 다음 연속적으로 계대배양을 
시행하여 최종분화 및 복제노화가 일어난 세포들을 채득하였으며, 이들 세포에서 
최종분화 및 복제노화가 유도되었음을 단백질 및 RNA 수준에서 확인하였다. 빨리 
증식하는 구강각화세포와 최종분화 및 복제노화가 일어난 구강각화세포에서 
tRNA를 분리한 다음 Affymetrix사의 Human Genome U133 Plus 2.0 Array를 이용하여 
마이크로어레이를 시행하였다. 마이크로어레이에 의한 유전자 발현 결과는 real-time 
RT-PCR 방법으로 확인하였다. 또한 생물정보학 분석 소프트웨어인 Ingenuity 
Pathway Analysis (IPA)를 이용하여 최종분화 및 복제노화과정에서 얻은 유전자 발현 
변화로부터 유전자 네트워크와 주요기능을 분석하였다. 또한 기능분석을 토대로 
사람 구강각화세포에서 염증반응에 관련된 유전자의 기능을 연구하기 위하여 빨리 
증식하는 사람 구강각화세포에 IL-1β를 12~96시간 처리하였으며, 최종분화 및 
복제노화가 일어난 세포에 IL-1β 중화항체를 14일간 처리한 후 분석하였다. 나아가 
이를 생체조직에서 확인하기 위하여, 생후 3개월 된 쥐와 생후 2년 된 쥐의 
치은조직에서 최종분화 및 복제노화관련 유전자 발현을 면역세포화학염색법으로 
확인하였다. 일차배양한 사람 정상 구강각화세포를 연속적으로 계대배양 시 




및 복제노화가 일어난 사람 구강각화세포에서 1,247종의 유전자는 발현이 
증가되었고 1,219종의 유전자는 발현이 감소되었다. 발현이 변화된 유전자들은 주로 
수송, 세포증식, 세포주기, 면역반응, 세포사멸, 전사 및 염증반응에 관여하는 
유전자들이었다. 또한 사람 구강각화세포의 최종분화 및 복제노화가 일어남에 따라 
IL-1β, S100A8, S100A9, MMP1, MMP9, IL-8, BHLHB2, HES1 및 TWIST1 유전자의 
발현이 현저하게 높아졌다. 염증유발관련 유전자(IL-1β 및 IL-8) 발현이 높은 것을 
확인하기 위하여 IL-1β 및 IL-1β 중화항체를 사람 정상 구강각화세포에 처리한 결과, 
IL-1β 처리한 세포에서는 IL-1β, S100A8, S100A9, MMP1, MMP9 및 IL-8의 발현이 
증가하였으나 IL-1β 중화항체를 처리한 세포에서는 발현이 감소하였다. 또한 생체의 
노화된 조직에서 최종분화 및 복제노화 관련유전자의 발현변화를 연구한 결과, 
생후 3개월 된 쥐와 비교할 때 생후 2년 된 쥐의 치은조직에서 involucrin과 
p16INK4A의 발현이 증가되었으며, DEC1(Bhlhb2)과 IL-1β 발현이 증가됨을 확인하였다. 
이상의 연구결과, 사람 구강각화세포의 최종분화 및 복제노화 과정에서 유전자 
발현변화를 포괄적으로 분석하였으며, 나아가 분자 네트워크 및 생물학적 주요 
기능의 일단을 밝혀 사람 정상 상피세포의 분화 및 노화과정을 이해하는데 큰 
도움을 줄 것으로 생각된다. 
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